Trends in hypercholesterolemia, treatment and control among United States adults

International Journal of Cardiology

Volumn 140, Issue 2, 2010, Pages 226-235

  Ford, Earl S ^a   Li, Chaoyang ^a   Pearson, William S ^a   Zhao, Guixiang ^a   Mokdad, Ali H ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cholesterol; Epidemiology; Prevention; Risk factor

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; FEMALE; HISPANIC; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; ANTICHOLESTEREMIC AGENTS; BODY MASS INDEX; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MEXICAN AMERICANS; MIDDLE AGED; MYOCARDIAL INFARCTION; NUTRITION SURVEYS; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 77950369891     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.033     Document Type: Article

References (53)

1. The pooling project research group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chronic Dis 31 (1978) 201-306
2. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The expert panel. Arch Intern Med 148 (1988) 36-69
3. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 89 (1994) 1333-1445
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Johnson C.L., Rifkind B.M., Sempos C.T., et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 269 (1993) 3002-3008
6. Ford E.S., Mokdad A.H., Giles W.H., and Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 107 (2003) 2185-2189
7. Carroll M.D., Lacher D.A., Sorlie P.D., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294 (2005) 1773-1781
8. Cohen M.V., Byrne M.J., Levine B., Gutowski T., and Adelson R. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. Circulation 83 (1991) 1294-1304
9. Goldberg R.J., Ockene I.S., Yarzebski J., Savageau J., and Gore J.M. Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study). Am J Cardiol 79 (1997) 1095-1097
10. Schrott H.G., Bittner V., Vittinghoff E., Herrington D.M., and Hulley S. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. JAMA 277 (1997) 1281-1286
11. Frolkis J.P., Zyzanski S.J., Schwartz J.M., and Suhan P.S. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Circulation 98 (1998) 851-855
12. Elasy T.A., and Mehler P.S. Secondary prevention practices after acute myocardial infarction in a large city hospital. Am J Cardiol 82 (1998) 987-989
13. McBride P., Schrott H.G., Plane M.B., Underbakke G., and Brown R.L. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med 158 (1998) 1238-1244
14. Hoerger T.J., Bala M.V., Bray J.W., Wilcosky T.C., and LaRosa J. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am J Cardiol 82 (1998) 61-65
15. Gotto A.M. Lipid-lowering therapy for the primary prevention of coronary heart disease. J Am Coll Cardiol 33 (1999) 2078-2082
16. Sueta C.A., Chowdhury M., Boccuzzi S.J., et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 83 (1999) 1303-1307
17. Lai L.L., Poblet M., and Bello C. Are patients with hyperlipidemia being treated? Investigation of cholesterol treatment practices in an HMO primary care setting. South Med J 93 (2000) 283-286
18. Pearson T.A., Laurora I., Chu H., and Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
19. Fonarow G.C., French W.J., Parsons L.S., Sun H., and Malmgren J.A. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. Circulation 103 (2001) 38-44
20. Mazzolini T.A., Irons B.K., Schell E.C., and Seifert C.F. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers. J Manag Care Pharm 11 (2005) 763-771
21. Qayyum R., Chattha A.A., Bhullar N., Katsetos M., and Schulman P. Achievement of national cholesterol education program goals by patients with dyslipidemia in rural ambulatory care settings. Prev Cardiol 9 (2006) 192-197
22. Schwiesow S.J., Nappi J.M., and Ragucci K.R. Assessment of compliance with lipid guidelines in an academic medical center. Ann Pharmacother 40 (2006) 27-31
23. Stacy T.A., and Egger A. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs. J Manag Care Pharm 12 (2006) 745-751
24. Muntner P., DeSalvo K.B., Wildman R.P., Raggi P., He J., and Whelton P.K. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol 163 (2006) 913-920
25. Nag S.S., Daniel G.W., Bullano M.F., et al. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO. J Manag Care Pharm 13 (2007) 652-663
26. Lemaitre R.N., Furberg C.D., Newman A.B., et al. Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch Intern Med 158 (1998) 1761-1768
27. Arnett D.K., Jacobs Jr. D.R., Luepker R.V., Blackburn H., Armstrong C., and Claas S.A. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 112 (2005) 3884-3891
28. Centers for Disease Control and Prevention. Trends in cholesterol screening and awareness of high blood cholesterol-United States, 1991-2003. MMWR Morb Mortal Wkly Rep 54 (2005) 865-870
29. Hyre A.D., Muntner P., Menke A., Raggi P., and He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol 17 (2007) 548-555
30. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Accessed at http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm on August 19, 2008.
31. US Department of Health and Human Services. Healthy people 2010 (conference ed, 2 vols). Washington, DC: US Department of Health and Human Services, 2000.
32. Centers for Disease Control and Prevention. CDC State Heart Disease and Stroke Prevention Program. Atlanta, GA. Accessed at http://www.cdc.gov/cvh/state_program/index.htm on August 19, 2008.
33. Miller M., Byington R., Hunninghake D., Pitt B., and Furberg C.D. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med 160 (2000) 343-347
34. Corbelli J.A., Corbelli J.C., Bullano M.F., et al. Gender bias in lipid assessment and treatment following percutaneous coronary intervention. J Gend Specif Med 6 (2003) 21-26
35. O'Meara J.G., Kardia S.L., Armon J.J., Brown C.A., Boerwinkle E., and Turner S.T. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 164 (2004) 1313-1318
36. Hendrix K.H., Riehle J.E., and Egan B.M. Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis 15 (2005) 11-16
37. Nau D.P., and Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manag Care 11 (2005) 69-73
38. Kim C., Kerr E.A., Bernstein S.J., and Krein S.L. Gender disparities in lipid management: the presence of disparities depends on the quality measure. Am J Manag Care 12 (2006) 133-136
39. Cooke C.E., and Hammerash Jr. W.J. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization. Clin Ther 28 (2006) 591-599
40. Centers for Disease Control and Prevention. Disparities in screening for and awareness of high blood cholesterol-United States, 1999-2002. MMWR Morb Mortal Wkly Rep 54 (2005) 117-119
41. Nelson K., Norris K., and Mangione C.M. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 162 (2002) 929-935
42. Clark L.T., Maki K.C., Galant R., Maron D.J., Pearson T.A., and Davidson M.H. Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. J Gen Intern Med 21 (2006) 320-326
43. Goff Jr. D.C., Bertoni A.G., Kramer H., et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113 (2006) 647-656
44. National Committee for Quality Assurance. The State of Health Care Quality 2007. Accessed at http://www.ncqa.org/Portals/0/Publications/Resource%20Library/SOHC/SOHC_ 07.pdf on August 19, 2008.
45. Avorn J., and Choudhry N.K. Using computer-based decision support to close the "know do" gap in lipid-lowering therapy. Circulation 117 (2008) 336-337
46. van Wyk J.T., van Wijk M.A., Sturkenboom M.C., Mosseveld M., Moorman P.W., and van der L.J. Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: a cluster randomized controlled trial. Circulation 117 (2008) 371-378
47. Ofili E., Pemu P.I., Gulaya V., et al. Targeting healthcare disparities: an integrated model to improve treatment rates of dyslipidemia in African American patients. Curr Atheroscler Rep 7 (2005) 249-250
48. Gavish D., Leibovitz E., Elly I., Shargorodsky M., and Zimlichman R. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients. Isr Med Assoc J 4 (2002) 694-697
49. Lacy C.R., Suh D.C., Barone J.A., et al. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting. Arch Intern Med 162 (2002) 468-473
50. Till L.T., Voris J.C., and Horst J.B. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 9 (2003) 269-273
51. Collins C., Kramer A., O'Day M.E., and Low M.B. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health-Syst Pharm 63 (2006) 1723-1727
52. Farquhar D. Training opinion leaders to improve physician practice in the management of dyslipidemia. Acad Med 74 (1999) 613-614
53. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150